Substance use in LGBTQ+ populations

Dr. Daniel Demant is an Epidemiologist and Senior Lecturer in Public Health at the University of Technology Sydney and a Visiting Fellow in the School of Public Health and Social Work at the Queensland University of Technology, Brisbane, Australia. His research focuses on health in disadvantaged pop...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Q&A
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203782/
https://www.ncbi.nlm.nih.gov/pubmed/35721831
http://dx.doi.org/10.1038/s43856-022-00132-5
_version_ 1784728775364182016
collection PubMed
description Dr. Daniel Demant is an Epidemiologist and Senior Lecturer in Public Health at the University of Technology Sydney and a Visiting Fellow in the School of Public Health and Social Work at the Queensland University of Technology, Brisbane, Australia. His research focuses on health in disadvantaged populations and he has a particular interest in sexual health and substance use in LGBTQ+ populations. In this Q&A, we ask Dr. Demant a series of questions on disparities in substance use in LGBTQ+ people, the potential reasons underlying such disparities and harms associated with them, and the direction of research in this area.
format Online
Article
Text
id pubmed-9203782
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-92037822022-06-18 Substance use in LGBTQ+ populations Commun Med (Lond) Q&A Dr. Daniel Demant is an Epidemiologist and Senior Lecturer in Public Health at the University of Technology Sydney and a Visiting Fellow in the School of Public Health and Social Work at the Queensland University of Technology, Brisbane, Australia. His research focuses on health in disadvantaged populations and he has a particular interest in sexual health and substance use in LGBTQ+ populations. In this Q&A, we ask Dr. Demant a series of questions on disparities in substance use in LGBTQ+ people, the potential reasons underlying such disparities and harms associated with them, and the direction of research in this area. Nature Publishing Group UK 2022-06-16 /pmc/articles/PMC9203782/ /pubmed/35721831 http://dx.doi.org/10.1038/s43856-022-00132-5 Text en © Springer Nature Limited 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Q&A
Substance use in LGBTQ+ populations
title Substance use in LGBTQ+ populations
title_full Substance use in LGBTQ+ populations
title_fullStr Substance use in LGBTQ+ populations
title_full_unstemmed Substance use in LGBTQ+ populations
title_short Substance use in LGBTQ+ populations
title_sort substance use in lgbtq+ populations
topic Q&A
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203782/
https://www.ncbi.nlm.nih.gov/pubmed/35721831
http://dx.doi.org/10.1038/s43856-022-00132-5

Ejemplares similares